A new trading day began on August 04, 2022, with Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) stock priced at $1.23, up 6.90% from the previous day of trading. During the day, the shares moved up to $1.28 and dropped to $1.174 before settling in for the closing price of $1.16. CYCC’s price has ranged from $1.01 to $6.10 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
Meanwhile, its annual earnings per share averaged 37.40%. With a float of $9.53 million, this company’s outstanding shares have now reached $9.99 million.
The extent of productivity of a business whose workforce counts for 12 workers is very important to gauge.
Cyclacel Pharmaceuticals Inc. (CYCC) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cyclacel Pharmaceuticals Inc. is 1.40%, while institutional ownership is 41.40%. The most recent insider transaction that took place on Nov 30, was worth 43. In this transaction Director of this company sold 12 shares at a rate of $3.57, taking the stock ownership to the 3,374 shares. Before that another transaction happened on Nov 18, when Company’s President and CEO bought 4,000 for $4.50, making the entire transaction worth $18,000. This insider now owns 4,988 shares in total.
Cyclacel Pharmaceuticals Inc. (CYCC) Latest Financial update
In its latest quarterly report, released on 3/30/2022, the company reported earnings of -$0.42 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -53.56. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.40% per share during the next fiscal year.
Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) Trading Performance Indicators
Here are Cyclacel Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -3.19 in one year’s time.
Technical Analysis of Cyclacel Pharmaceuticals Inc. (CYCC)
The latest stats from [Cyclacel Pharmaceuticals Inc., CYCC] show that its last 5-days average volume of 0.78 million was superior to 0.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 42.90%. Additionally, its Average True Range was 0.13.
During the past 100 days, Cyclacel Pharmaceuticals Inc.’s (CYCC) raw stochastic average was set at 9.70%, which indicates a significant decrease from 32.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.01% in the past 14 days, which was higher than the 98.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2300, while its 200-day Moving Average is $2.8105. Now, the first resistance to watch is $1.2887. This is followed by the second major resistance level at $1.3373. The third major resistance level sits at $1.3947. If the price goes on to break the first support level at $1.1827, it is likely to go to the next support level at $1.1253. The third support level lies at $1.0767 if the price breaches the second support level.
Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) Key Stats
With a market capitalization of 11.97 million, the company has a total of 9,995K Shares Outstanding. Currently, annual sales are 0 K while annual income is -18,890 K. The company’s previous quarter sales were 0 K while its latest quarter income was -4,108 K.
